date:Nov 02, 2012
sales, he said.
In terms of the status of the yeast in Europe, he confirmed the product had not yet been commercially released in the EU, but that multiple trials were underway, with many complete.
The firm has tested on bread, toast, biscuits, crackers, extrusion products and various other snack foods. In all cases tested to date, Husnik said the yeast strains could reduce asparagine and/or acrylamide by 90% or more.
Like competing acrylamide-mitigating enzymes, Functional Technologies Corp'